| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/27/2003 | US20030219895 An oligonucleotide or a hybrids for encoding a protein kinase |
| 11/27/2003 | US20030219892 Illuminating the cells to obtain an image, determining the locations of specific individual cells, using energy beam to induce a response; detection, for drug delivery of genes into specific cells of interest |
| 11/27/2003 | US20030219891 An biological, optic apparatus for gene testing, optical sensor comprising pixels for detecting chemiluminescence between the reaction of biological sample and a reagent |
| 11/27/2003 | US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/27/2003 | US20030219884 Using laser beams to monitor and measuring electrical potential across transport/membrane proteins and/or g-protein coupled receptors; drug screening |
| 11/27/2003 | US20030219878 Using restriction independent cloning events (RICE) to prepare and ligate novel RNA sequences |
| 11/27/2003 | US20030219874 Comprises endothelial differentiation gene receptor proteins (EDG8) for monitoring receptivity to and/or diagnosing cancer, angiogenesis and inflammation |
| 11/27/2003 | US20030219873 Self-assembling recombinant papillomavirus capsid proteins |
| 11/27/2003 | US20030219870 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 11/27/2003 | US20030219866 Culturing pluripotent cells and monitoring expression of transcriptional marker protein (OCT4); animal models for cell differentiation; veterinary medicine |
| 11/27/2003 | US20030219849 Fluorescent phospholipase assay, phospholipase A2 inhibitor and stimulator, and the use thereof |
| 11/27/2003 | US20030219848 Comprises beta-galactosidase fragments for use as diagnostic tools in monitoring intracellular events; protein folding and solubility analysis |
| 11/27/2003 | US20030219847 Alpha-Dicarbonyl compounds can be used to covalently modify and thereby inactivate prenylating enzymes such as protein farnesyltransferase and protein geranylgeranyltransferase |
| 11/27/2003 | US20030219846 Assay for activity of the ActRIIB kinase |
| 11/27/2003 | US20030219844 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein |
| 11/27/2003 | US20030219841 Method and reagent for the detection of apoptotic cells and of a protease activated during apoptosis |
| 11/27/2003 | US20030219831 Split-hybrid system |
| 11/27/2003 | US20030219825 High throughput method for screening candidate compounds for biological activity |
| 11/27/2003 | US20030219820 Using differential scanning calorimetry to monitor hydrophobic, covalent, ionic, or hydrogen bonding interactions associated with proteins and/or polynucleotides under heated conditions; high throughput assay |
| 11/27/2003 | US20030219819 Method for improving efficiencies in livestock production |
| 11/27/2003 | US20030219818 Evaluating patient response to antiproliferative/antitumor agents; immunotherapy |
| 11/27/2003 | US20030219817 Preparing and screening immunoglobulin libraries; analyzing binding activity of affinity pairs; mimetic for treatment of autoimmune, cancer, viral and asthma disorders |
| 11/27/2003 | US20030219815 Using restriction fragment length polymorphism to determine sequence compostion at preferential genomic position; forensics; diagnosing genetic disorders |
| 11/27/2003 | US20030219812 Methods and devices for obtaining and assaying mammary fluid samples for evaluating breast diseases, including cancer |
| 11/27/2003 | US20030219811 Comprises nucleotide sequences for diagnosing tuberculosis infection and mycobacterial infections |
| 11/27/2003 | US20030219810 Polymorphisms in the human CARD4 gene |
| 11/27/2003 | US20030219808 Association of EDG5 polymorphism V286A with type II Diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof |
| 11/27/2003 | US20030219807 Monitoring organismal response to treatments for neurodegenerative/ischemic damages/diseases |
| 11/27/2003 | US20030219806 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor |
| 11/27/2003 | US20030219805 Detection of alternative and aberrant mRNA splicing |
| 11/27/2003 | US20030219804 Anchored strand displacement amplification on an electronically addressable microchip |
| 11/27/2003 | US20030219803 Using molecular probes for determining in situ positioning of biopolymer targets; high throughput assay |
| 11/27/2003 | US20030219802 Diagnosis and treatment of osteosarcoma |
| 11/27/2003 | US20030219801 Aptamer base technique for ligand identification |
| 11/27/2003 | US20030219797 Statistical modeling to analyze large data arrays |
| 11/27/2003 | US20030219796 Method of testing for allergic disease |
| 11/27/2003 | US20030219795 Identifying modulators of tumor suppressor genes; antitumor/antiproliferative/anticarcinogenic agents |
| 11/27/2003 | US20030219794 Comprises nucleotide sequences coding enzymatic polypeptide associated with purine nucleotide biosynthesis for use as cancer diagnositic markers; antiproliferative/antitumor agents |
| 11/27/2003 | US20030219792 Using recombinase-polymerase amplification to propagate target DNA without the use of thermocycling or thermophilic enzymes |
| 11/27/2003 | US20030219791 Transducer of MAS signalling |
| 11/27/2003 | US20030219790 Polynucleic acid nanomechanical device controlled by hybridization topology |
| 11/27/2003 | US20030219789 36P6D5: secreted tumor antigen |
| 11/27/2003 | US20030219788 Determining concentration of nucleotide sequences in sample; diagnosing microrganismal infection |
| 11/27/2003 | US20030219787 Comprises nucleotide sequences for detecting and analyzing restriction fragment length polymorphhisms associated with information processing brain disorders |
| 11/27/2003 | US20030219784 Using nucleic acid based bioassay to determine quality of grains |
| 11/27/2003 | US20030219782 Identifying agents which modulate sphingolipid metabolism; drug screening; antiproliferative agents; diagnosing muscular and cancer disorders |
| 11/27/2003 | US20030219781 Compositions and methods for making polynucleotides by iterative assembly of codon building blocks |
| 11/27/2003 | US20030219779 Transposon mediated multiplex sequencing |
| 11/27/2003 | US20030219778 Method for the diagnosis, identification and characterization of M. tuberculosis and other mycobacteria by shift mobility assay |
| 11/27/2003 | US20030219777 Comprises expression vector coding sequences for detecting gene position of atherosclerosis susceptibility gene and for modulating cholesterol phenotypes in cells |
| 11/27/2003 | US20030219776 Molecular variants, haplotypes and linkage disequilibrium within the human angiotensinogen gene |
| 11/27/2003 | US20030219775 Nucleic acid diagnostic reagents and methods for detecting nucleic acids, polynucleotides and oligonucleotides |
| 11/27/2003 | US20030219773 Using restriction independent cloning events (RICE) to generate recombinant nucleotide sequences |
| 11/27/2003 | US20030219772 Evaluating effectiveness of cancer treatment; drug screening |
| 11/27/2003 | US20030219771 Using transcriptional products to diagnose metabolic disorders such as cancer and diabetes |
| 11/27/2003 | US20030219770 Simultaneous single-direction sequencing of multiple genes or forward and reverse sequencing from single gene, within single reaction vessel; combined amplification and sequencing of nucleic acids from variety of sources within single reaction |
| 11/27/2003 | US20030219769 Methods for genetic analysis of DNA using biased amplification of polymorphic sites |
| 11/27/2003 | US20030219768 Lung cancer therapeutics and diagnostics |
| 11/27/2003 | US20030219767 Detecting and classifying estrogen negative and estrogen positive mamary gland tumors |
| 11/27/2003 | US20030219766 Comprises nucleotide sequences coding human leukocyte antigen conjugate for use in diagnosis, prognosis and treatment of cell proliferative disorders; antiproliferative agents |
| 11/27/2003 | US20030219765 Methods for evaluating cancer risk |
| 11/27/2003 | US20030219764 Using mathematical models associated with mutational analysis to observe, determine and detect genes associated with preferential metabolic pathways |
| 11/27/2003 | US20030219763 Plant protoplast gene expression systems and uses thereof |
| 11/27/2003 | US20030219761 Novel prostate-specific or test-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/27/2003 | US20030219760 Diagnostic and prognostic tests |
| 11/27/2003 | US20030219759 Using nucleotide sequence expression for monitoring, evaluating and developing prognosis associated with stroke patient |
| 11/27/2003 | US20030219758 Comprises nucleotide sequences for diagnosis, prevention and treatment of metastasis, autoimmune and nervous system disorders |
| 11/27/2003 | US20030219757 Comprises oligonucleotide probe for diagnosing tuberculosis |
| 11/27/2003 | US20030219755 Methods of signal amplification in nucleic acid hybridization reactions that permit the detection of low numbers of target nucleic acids; sensitivity is enhanced via complex target and probe interactions |
| 11/27/2003 | US20030219754 Apparatus for replication and identification of labeled nucleotide sequences |
| 11/27/2003 | US20030219752 Preparing immunoglobulin library; high throughput assay; immunoassays; immunotherapeutics and/or diagnostics; anticarcinogenic agents |
| 11/27/2003 | US20030219751 Universal-tagged oligonucleotide primers and methods of use |
| 11/27/2003 | US20030219750 Schizophrenia associated genes, proteins and biallelic markers |
| 11/27/2003 | US20030219749 Comprises primers for replication and detection of genes associated with antibiotic resistance gram negative bacteria; ampicillin resistance |
| 11/27/2003 | US20030219746 Comprises oligonucleotide sequence for diagnosing and prognosing cancer |
| 11/27/2003 | US20030219741 Novel full-length cDNA |
| 11/27/2003 | US20030219740 DNA sequences isolated from human colonic epithelial cells |
| 11/27/2003 | US20030219739 Comprises muscle protein for treating and preventing of muscle atrophy |
| 11/27/2003 | US20030219737 Identifying bacterial holoenzyme for use in screening antibiotics and as tool in DNA synthesis/amplification |
| 11/27/2003 | US20030219736 Using DNA microarrays to analyze and identify patterns of bacterial gene expression and transcriptional changes throughout genome |
| 11/27/2003 | US20030219735 Genetically engineered adeno-associated viral vector comprising single stranded heterologous nucleotide sequence for use as tool diagnostic tool in gene therapy and genomic screening |
| 11/27/2003 | US20030219732 Adaptation sites of porcine reproductive and respiratory syndrome virus |
| 11/27/2003 | US20030219731 Monitoring binding association using laser desorption ionization probes; spectrum analysis |
| 11/27/2003 | US20030219730 Comprises nucleotide sequences associated with small round structured viruses (SRSVs) for use as diagnostic tool in detecting food poisoning; hygienic testing |
| 11/27/2003 | US20030219727 Prodrugs of phosphonate nucleotide analogues |
| 11/27/2003 | US20030219726 Detection of abnormalities leading to cervical malignancy |
| 11/27/2003 | US20030219725 Using polymerase chain reaction to determine nucleotide sequences of a lymphadenopathy associated virus; genetic engineering |
| 11/27/2003 | US20030219723 Bioassys for identifying hepatitis C viricidal agents; drug screening |
| 11/27/2003 | US20030219720 Monitoring and identifying drugs which serve as neuroprotectants in the prevention of alzheimer's disease; drug screening |
| 11/27/2003 | US20030219719 Monitoring perfusion of fluids in or through viable/living tissues; neurosurgy and organ transplantation; aniscarring agents |
| 11/27/2003 | US20030219715 Cell-based analysis of high throughput screening data for drug discovery |
| 11/27/2003 | US20030219714 Apparatus for identifying and characterizing toxic compounds; drug screening; side effect reduction |
| 11/27/2003 | US20030219713 Microarrays comprising immobilized biopolymers for monitoring, measuring and analyzing blood components; microfluidics |
| 11/27/2003 | US20030219454 Isolated from Haemophilus paragallinarum; for vaccinating chickens against infectious coryza |
| 11/27/2003 | US20030219443 Mycobacterium tuberculosis superoxide dismutase |
| 11/27/2003 | US20030219422 Polyucleotides having hammerhead motif used for detection and analysis; biosensors |
| 11/27/2003 | US20030219413 Method for overexpression of zwitterionic polysaccharides |
| 11/27/2003 | US20030219403 Compositions and methods of tolerizing a primate to an antigen |
| 11/27/2003 | US20030219385 Contrast agents for magnetic resonance imaging and methods related thereto |
| 11/27/2003 | US20030219382 Cancer-linked gene as target for chemotherapy |